TTrialPathMatch Me to Trials
← Back to trials
RecruitingAlzheimer's Disease

Neuroplasticity Enhancement From Cognitive Training Reinforced by Psilocybin

Eligible age

65–120 yrs

Accepts

All genders

Locations

1 state

Healthy volunteers

Yes

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

Background: Normal aging, as well as dementias such as Alzheimer s disease, can cause changes in the brain that affect memory, attention, and thinking. Researchers want to know if regular mental tasks (cognitive training) can improve brain function in older adults. They also want to know if psilocybin, a compound found in certain mushrooms, can further support improved brain function. Objective: To learn how regular cognitive training, with or without psilocybin, can improve brain health in older adults. Eligibility: People aged 65 years and older with mild cognitive impairment or early-stage Alzheimer s disease. Healthy older adults with normal cognition are also needed. Design: Participants will be screened. They will have a test of their heart function and an imaging scan. They will have mental health screening and tests of their thinking and memory. They will practice brain-training tasks on a tablet. Participants will be divided into 2 groups: 1 will have cognitive training plus psilocybin; 1 will have cognitive training only. Those having cognitive training only will have 5 or 6 clinic visits. They will take the tablet home to practice brain training daily. They will wear a device to measure brain waves as they sleep; they may have 1 overnight stay in the clinic, or they may wear the device at home. Imaging scans and other tests will be repeated at each visit. Those taking psilocybin will have up to 9 clinic visits. In addition to the visits for cognitive training, they will take 1 psilocybin capsule by mouth 2 weeks apart (the second dose is optional). They will remain in the clinic for 24 hours after each dose.

Sponsor: National Institute on Aging (NIA)

You may not qualify if…

  • ✕ An individual who meets any of the following criteria will be excluded from participation in this study:
  • ✕ Medical history
  • ✕ -Neurological disorders (besides AD): Brain disorders, either previously diagnosed or revealed through screening exams or baseline neuroimaging, including:
  • ✕ Stroke (except single asymptomatic old lacune)
  • ✕ Transient Ischemic Attack (TIA) within the past year, unless work-up shows no ongoing risk
  • ✕ Extensive microvascular pathology or microbleeds
  • ✕ Multiple sclerosis or demyelinating disorders
  • ✕ Parkinson s disease or movement disorders (e.g., Multiple Systems Atrophy, Progressive Supranuclear Palsy)

Where it's recruiting

Maryland

Baltimore

Source: ClinicalTrials.gov · NCT07721467 · last updated 2026-11-20

Neuroplasticity Enhancement From Cognitive Training Reinforced by Psil · TrialPath